Meet BLA Regulatory at Medtec Japan & BIO KOREA 2026
BLA Regulatory announces CEO participation at Medtec Japan 2026 and BIO KOREA 2026. Connect with us on-site to discuss FDA...
Dr. Li to Attend BioJapan 2025 — Let’s Connect!
Submitting an IND application to the US FDA is a significant step in the development of a new drug or...
BLA joins in iPark-KBIC Meetup at BIO Boston
Submitting an IND application to the US FDA is a significant step in the development of a new drug or...
Meet BLA at BIO International Convention 2025
Submitting an IND application to the US FDA is a significant step in the development of a new drug or...
Bioeconomy Hub Japan 2025 – Strengthening Global Collaboration in Bioeconomy
Submitting an IND application to the US FDA is a significant step in the development of a new drug or...
US FDA IND Application Strategy & Execution
Submitting an IND application to the US FDA is a significant step in the development of a new drug or...